Livzon Pharmaceutical Group (000513.SZ) Osake Kurssi

Livzon Pharmaceutical Group Inc is primarily active in the pharmaceutical industry. As a renowned company, Livzon Pharmaceutical Group Inc is engaged in the research, development, production, and distribution of a wide range of pharmaceutical products. With a strong focus on innovation and quality, Livzon Pharmaceutical Group Inc provides various healthcare solutions, including prescription drugs, over-the-counter medications, and medical devices. With its extensive portfolio and expertise in the pharmaceutical sector, Livzon Pharmaceutical Group Inc has made significant contributions to improving healthcare and enhancing the well-being of individuals worldwide.

The main competitors of Livzon Pharmaceutical Group Inc in the market include multinational pharmaceutical companies such as Pfizer, Novartis, and Johnson & Johnson. These companies also operate in the same industry, manufacturing and distributing a wide range of pharmaceutical products and medications. Livzon Pharmaceutical Group Inc faces competition from these established players in terms of product innovation, market share, and global presence. In order to remain competitive, Livzon Pharmaceutical Group Inc focuses on its research and development capabilities, commercial partnerships, and strategic alliances to differentiate itself in the market.

Livzon Pharmaceutical Group Inc is a leading pharmaceutical company based in China. Founded in 1992, Livzon has established itself as a major player in the healthcare industry, specializing in research, development, manufacturing, and marketing of pharmaceutical products. With a strong focus on innovation and quality, Livzon offers a diverse range of prescription drugs, over-the-counter medications, and healthcare products to meet the needs of patients and consumers worldwide. Over the years, Livzon has achieved significant milestones and expanded its presence both domestically and internationally. Today, Livzon Pharmaceutical Group Inc continues to strive for excellence in delivering safe and effective medical solutions for global healthcare challenges.

Livzon Pharmaceutical Group Inc, a leading pharmaceutical company, has achieved several significant milestones. Over the years, Livzon Pharmaceutical Group Inc has successfully developed and launched a wide range of innovative and high-quality pharmaceutical products. The company has demonstrated continuous growth and expansion, establishing a strong presence both domestically and internationally. Livzon Pharmaceutical Group Inc has also made significant investments in research and development, leading to breakthroughs in the medical field. With a strong commitment to healthcare and an impressive track record, Livzon Pharmaceutical Group Inc remains at the forefront of the pharmaceutical industry, striving to improve global health and well-being.

Livzon Pharmaceutical Group Inc is primarily present in China. The company, headquartered in Zhuhai, Guangdong province, operates mainly within the domestic market. Specializing in the research, development, manufacturing, and marketing of pharmaceutical products, Livzon serves customers across various provinces and cities in China. With a wide range of therapeutic areas covered, including traditional Chinese medicine, Livzon Pharmaceutical Group Inc is committed to contributing to the health and well-being of the Chinese population through its innovative pharmaceutical offerings.

Livzon Pharmaceutical Group Inc represents values of integrity, innovation, and dedication to the well-being of patients. With a strong corporate philosophy focused on research and development, Livzon strives to provide high-quality pharmaceutical products and services. The company emphasizes ethical business practices and adheres to strict quality standards in order to deliver safe and effective medicines. By continuously promoting technological advancements and investing in talent, Livzon aims to contribute positively to the healthcare industry, while prioritizing the needs of patients. This commitment to excellence is evident in every aspect of Livzon Pharmaceutical Group Inc's operations, making it a trusted name in the pharmaceutical sector.

Analyytikot asettavat tällä hetkellä Livzon Pharmaceutical Group-osakkeelle keskimääräisen tavoitehinnan 44,68 CNY (mediaani: 45,65 CNY), mikä merkitsee +59,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.

Livzon Pharmaceutical Group Analyytikkojen kursstavoitteet 2026

9 analyytikkoa arvioi tällä hetkellä Livzon Pharmaceutical Group-osaketta: 6 suosittaa ostoa, 2 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Livzon Pharmaceutical Group-yhtiöltä 9,98 Mrd. CNY liikevaihtoa ja 1,93 CNY osakekohtaista tulosta.

Livzon Pharmaceutical Group Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Livzon Pharmaceutical Group-osake noteerataan hintaan 3,94 EUR (29,29 CNY).

Livzon Pharmaceutical Group-osake (000513.SZ) on listattuna 1 pörssissä, muun muassa: Shenzhen (000513.SZ).

Livzon Pharmaceutical Group Inc is a pharmaceutical company based in China that specializes in the manufacturing, selling, and marketing of medicines and healthcare products. The company was founded in 1985 and has since grown to become one of the leading Chinese pharmaceutical companies. The business model of Livzon includes several divisions. The main divisions of the company involve the manufacturing and selling of prescription and over-the-counter drugs, medical devices, and healthcare products, as well as research and development of new medicines and therapies. Livzon produces a wide range of medicines including anti-cancer drugs, antiviral drugs, antibiotics, hormone preparations, immunomodulators, and cardiovascular drugs. These drugs are sold under various brand names and are available on the Chinese and international market. The company also has a division for medical devices including diagnosis, monitoring, and therapy devices. The focus here is on products for cardiology, neuroscience, and emergency medicine. Livzon also produces healthcare products including vitamins, dietary supplements, and drugs for improving physical performance. Livzon is also heavily involved in research and development of new medicines and therapies. The company has a team of experts and researchers who continuously work on developing new and more effective treatments for various diseases. Livzon Pharmaceutical Group Inc has a strong distribution network that spans across China and the international market. The company distributes its products through a wide network of distribution partners, retailers, and online platforms. As a rapidly growing company, Livzon Pharmaceutical Group Inc has experienced high growth rates in revenue and profit in recent years. The company also has a strong financial foundation and is well positioned to continue growing and expanding into new markets. Overall, Livzon Pharmaceutical Group Inc has a successful business model that focuses on the production of high-quality and effective medicines and healthcare products, as well as the development of new therapies. With a strong distribution network and a solid financial foundation, the company is in an excellent position to continue growing and increasing its market presence.

odotettu liikevaihto Livzon Pharmaceutical Group on 9,98 Mrd. CNY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Livzon Pharmaceutical Group on 1,71 Mrd. CNY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Livzon Pharmaceutical Group:n hinta-voitto-suhde (P/E) on tällä hetkellä 15,19. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Livzon Pharmaceutical Group-osakkeen arvostusta.

Livzon Pharmaceutical Group:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,61. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Livzon Pharmaceutical Group-osakkeen arvostuskennuslukuna.

Livzon Pharmaceutical Group:n Eulpool-laatuscore on 5/10.

Livzon Pharmaceutical Group:n ISIN on CNE0000002Y8. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Livzon Pharmaceutical Group:n ticker on 000513.SZ. Tämä pörssinoteeraus käytetään Livzon Pharmaceutical Group-osakkeiden kauppaan pörssissä.